Skip to main content

Table 4 The Cox proportional hazards model of PSA-PFS

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

   Hazard-ratio p 95 % CI
D’Amico Low 1   
Intermediate 1.212 0.493 0.693-2.119
High 2.116 0.003 1.289-3.492
J-CAPRA Low 1   
Intermediate 2.623 <0.001 1.942-3.542
Our new grouping Low 1   
Intermediate 1.936 <0.001 1.350-2.778
High 3.408 <0.001 2.269-5.117
  1. PSA-PFS: PSA progression-free survival
  2. 95 % CI: 95 % confidence interval